- Akamai Technologies : FBN Securities maintains its outperform rating and reduces the target price from USD 120 to USD 110.
- Arista Networks : Argus Research Company maintains its buy recommendation and raises the target price from USD 450 to USD 475.
- Bristol-Myers Squibb Company : Deutsche Bank maintains its hold recommendation with a price target raised from 48 to USD 55.
- Cvs Health Corporation : TD Cowen maintains its buy recommendation and reduces the target price from USD 85 to USD 73.
- Eaton Corporation : Vertical Research Partners maintains its buy recommendation and raises the target price from USD 355 to USD 375.
- Fluor Corporation : Citigroup maintains its buy recommendation with a price target reduced from USD 65 to USD 60.
- Gen Digital : Argus Research Company maintains its buy recommendation and raises the target price from USD 29 to USD 34.
- Genpact Limited : Mizuho Securities maintains a neutral recommendation with a price target raised from 40 to USD 45.
- Illinois Tool Works : Vertical Research Partners maintains its hold recommendation with a price target raised from USD 265 to USD 275.
- Ingersoll Rand : Vertical Research Partners maintains its buy recommendation and raises the target price from USD 110 to USD 120.
- Johnson Controls International : Vertical Research Partners maintains its hold recommendation with a price target raised from USD 80 to USD 85.
- Moderna : Citigroup remains outperform recommendation with a price target reduced from USD 96 to USD 86.
- Nvent Electric : Vertical Research Partners maintains its buy recommendation and raises the target price from USD 76 to USD 85.
- Otis Worldwide Corporation : Vertical Research Partners maintains its hold recommendation with a price target raised from USD 95 to USD 100.
- Parker-Hannifin Corporation : Vertical Research Partners maintains its buy recommendation and raises the target price from USD 660 to USD 725.
- Regeneron Pharmaceuticals : Argus Research Company maintains its buy recommendation and reduces the target price from USD 1175 to USD 1000.
- Trane Technologies : Vertical Research Partners maintains its hold recommendation with a price target raised from USD 395 to USD 415.
- Us Foods Holding Corp. : CL King & Associates maintains its buy recommendation and raises the target price from USD 65 to USD 75.
- Vertiv Holdings Co : Vertical Research Partners maintains its buy recommendation and raises the target price from USD 130 to USD 140.
- Watsco : Vertical Research Partners maintains its hold recommendation with a price target raised from USD 490 to USD 550.
Analyst recommendations: Moderna, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Arista Networks...
Every morning, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information can be used to shed light on movements in certain stocks or on market sentiment towards a company.